Correlation Between India Glycols and Aarey Drugs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both India Glycols and Aarey Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining India Glycols and Aarey Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between India Glycols Limited and Aarey Drugs Pharmaceuticals, you can compare the effects of market volatilities on India Glycols and Aarey Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in India Glycols with a short position of Aarey Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of India Glycols and Aarey Drugs.

Diversification Opportunities for India Glycols and Aarey Drugs

0.65
  Correlation Coefficient

Poor diversification

The 3 months correlation between India and Aarey is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding India Glycols Limited and Aarey Drugs Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aarey Drugs Pharmace and India Glycols is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on India Glycols Limited are associated (or correlated) with Aarey Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aarey Drugs Pharmace has no effect on the direction of India Glycols i.e., India Glycols and Aarey Drugs go up and down completely randomly.

Pair Corralation between India Glycols and Aarey Drugs

Assuming the 90 days trading horizon India Glycols Limited is expected to generate 1.21 times more return on investment than Aarey Drugs. However, India Glycols is 1.21 times more volatile than Aarey Drugs Pharmaceuticals. It trades about -0.08 of its potential returns per unit of risk. Aarey Drugs Pharmaceuticals is currently generating about -0.22 per unit of risk. If you would invest  120,550  in India Glycols Limited on November 28, 2024 and sell it today you would lose (8,045) from holding India Glycols Limited or give up 6.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

India Glycols Limited  vs.  Aarey Drugs Pharmaceuticals

 Performance 
       Timeline  
India Glycols Limited 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days India Glycols Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.
Aarey Drugs Pharmace 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Aarey Drugs Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in March 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

India Glycols and Aarey Drugs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with India Glycols and Aarey Drugs

The main advantage of trading using opposite India Glycols and Aarey Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if India Glycols position performs unexpectedly, Aarey Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aarey Drugs will offset losses from the drop in Aarey Drugs' long position.
The idea behind India Glycols Limited and Aarey Drugs Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Global Correlations
Find global opportunities by holding instruments from different markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device